文献速递冠心病外科

双支冠状动脉病变混合冠状动脉血运重建的短期与中期结局

Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-04-30

该回顾性队列研究将2009年1月至2016年12月本中心207例双支冠状动脉病变行混合冠状动脉血运重建的患者与207例倾向匹配的冠状动脉旁路移植术患者比较,发现两组30天死亡率均为0.5%,8年生存率分别为90.3%与87.9%,混合血运重建组住院时间及围术期输血需求更低。

要点

  • 混合血运重建组与冠状动脉旁路移植术组30天死亡率均为0.5%(各1例)。
  • 混合血运重建组8年生存率为90.3%(187/207),冠状动脉旁路移植术组为87.9%(182/207)。
  • 终末期肾病独立预测所有患者晚期死亡(总体HR 5.60,P<.001)。

核心结论

  • 双支冠状动脉病变行混合冠状动脉血运重建与传统冠状动脉旁路移植术相比,短期结局和中期生存率相似。
  • 混合冠状动脉血运重建与更低的输血需求和更短的住院时间相关。

研究设计与样本

  • 回顾性综述本中心前瞻性收集的2009年1月至2016年12月数据库。
  • 将207例因双支血管病变行混合冠状动脉血运重建的患者与行冠状动脉旁路移植术的患者进行倾向匹配。
  • 8年生存数据来自国家死亡指数。

主要发现

  • 混合冠状动脉血运重建组30天死亡1例(0.5%),冠状动脉旁路移植术组30天死亡1例(0.5%)。
  • 混合冠状动脉血运重建组8年生存187/207例(90.3%),冠状动脉旁路移植术组182/207例(87.9%)。
  • 终末期肾病独立预测所有患者晚期死亡(总体风险比5.60,P<.001;混合冠状动脉血运重建风险比5.58,P=.002;冠状动脉旁路移植术风险比4.59,P=.006)。
  • 行混合冠状动脉血运重建的女性患者晚期死亡发生率更高(风险比2.47,P=.05)。
  • 混合冠状动脉血运重建组住院时间和围术期输血需求更低(P<.0001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to evaluate midterm survival data and resource use for patients who received hybrid coronary revascularization for 2-vessel coronary disease (robotic-assisted left internal thoracic artery graft to left anterior descending coronary artery (minimally invasive direct coronary artery bypass), coupled with a stent to the circumflex or right coronary artery), compared with a concurrent cohort who had traditional coronary artery bypass grafting. METHODS: A comprehensive retrospective review was undertaken of our prospectively collected database from January 2009 to December 2016. We propensity matched 207 patients who underwent hybrid coronary revascularization for double-vessel disease with patients who underwent coronary artery bypass grafting. Eight-year survival data were obtained from the National Death Index. RESULTS: Thirty-day mortality was 1 patient (0.5%) in each of the hybrid coronary revascularization and coronary artery bypass grafting groups. Eight-year survival for the hybrid coronary revascularization group was 187 of 207 patients (90.3%) compared with 182 of 207 patients (87.9%) for the coronary artery bypass grafting cohort. End-stage renal disease independently predicted late mortality in all patients (overall hazard ratio, 5.60, P < .001; hybrid coronary revascularization hazard ratio, 5.58, P = .002; coronary artery bypass grafting hazard ratio, 4.59, P = .006). Female patients who underwent hybrid coronary revascularization had a higher incidence of late death (hazard ratio, 2.47, P = .05). Length of stay and perioperative transfusion requirements were lower in the hybrid coronary revascularization group (P < .0001). CONCLUSIONS: Hybrid coronary revascularization for double-vessel coronary disease is associated with similar short-term outcomes and intermediate-term survival as traditional coronary artery bypass grafting. Hybrid coronary revascularization is associated with lower transfusion requirements and a shorter length of stay than coronary artery bypass grafting.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Patel NC, Hemli JM, Kim MC, et al. Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease. J Thorac Cardiovasc Surg. 2018. PMID: 30119899. doi:10.1016/j.jtcvs.2018.04.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。